Successful treatment and prevention of the recurrence of refractory vernal keratoconjunctivitis with dupilumab

Clin Exp Ophthalmol. 2022 Dec;50(9):1100-1103. doi: 10.1111/ceo.14142. Epub 2022 Aug 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Conjunctivitis, Allergic* / drug therapy
  • Humans
  • Keratoconjunctivitis*

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized